medigraphic.com
SPANISH

MediSan

ISSN 1029-3019 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2012, Number 09

<< Back Next >>

MediSan 2012; 16 (09)

Treatment of patients with vulgar psoriasis through electromagnetic field of extremely low frequency

Batista RM, Soriano GBI, Bergues CLE
Full text How to cite this article

Language: Spanish
References: 0
Page: 1399-1407
PDF size: 185.21 Kb.


Key words:

vulgar psoriasis, extremely low frequency electromagnetic field, cade ointment, dermatology department, secondary health care.

ABSTRACT

A controlled and randomized clinical therapeutical assay in phase III was carried out in 52 patients with vulgar psoriasis, who were assisted in the Dermatology department of "Dr. Joaquín Castillo Duany" Clinical Surgical Hospital in Santiago de Cuba, from 2005 to 2010 who were divided into 2 groups (26 members each): the active group which was conventionally treated with 20% cade ointment; and the experimental group, to which the extremely low frequency electromagnetic field was applied, with the objective of determining the effectiveness of this field in those affected during the periods of crisis and intercrisis. The studied population was clinically characterized by means of a frequency analysis, while the hypothesis tests were used for the evaluation of proportions which null hypothesis were accepted with 5 % as maximum error. In the series the used field was effective to treat the disorder during crisis and more effective than the cade ointment to prolong the intercrisis stage, without causing adverse reactions, so that it constituted a new alternative therapy that can be generalized in the dermatological services of the country, in order to improve the life quality of those who suffer that dermatosis.





2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

MediSan. 2012;16